These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 16819376

  • 1. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment.
    Walther F, Fusch C, Radke M, Beckert S, Findeisen A.
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):42-51. PubMed ID: 16819376
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B, Sayyah A, Bashashati M, Jazayeri H, Zand S.
    Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
    [Abstract] [Full Text] [Related]

  • 3. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
    Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM.
    Gut; 1998 Feb; 42(2):188-94. PubMed ID: 9536942
    [Abstract] [Full Text] [Related]

  • 4. Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study.
    Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Mäkitie O.
    J Pediatr; 2014 Jun; 164(6):1436-43.e1. PubMed ID: 24650398
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.
    Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT.
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625
    [Abstract] [Full Text] [Related]

  • 6. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
    Frei P, Fried M, Hungerbuhler V, Rammert C, Rousson V, Kullak-Ublick GA.
    Digestion; 2006 Mar; 73(1):40-6. PubMed ID: 16543736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel disease.
    Koutroubakis IE, Zavos C, Damilakis J, Papadakis G, Neratzoulakis J, Karkavitsas N, Kouroumalis EA.
    J Clin Gastroenterol; 2011 Jul; 45(6):e60-5. PubMed ID: 20921904
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density in children with moderate to severe atopic dermatitis.
    van Velsen SG, Knol MJ, van Eijk RL, de Vroede MA, de Wit TC, Lam MG, Haeck IM, de Bruin-Weller MS, Bruijnzeel-Koomen CA, Pasmans SG.
    J Am Acad Dermatol; 2010 Nov; 63(5):824-31. PubMed ID: 20850893
    [Abstract] [Full Text] [Related]

  • 14. [Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease].
    Scheer K, Kratzsch J, Deutscher J, Gelbrich G, Borte G, Kiess W.
    Klin Padiatr; 2004 Nov; 216(2):62-6. PubMed ID: 15106075
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for low bone mineral density in children and adolescents with inflammatory bowel disease.
    Lopes LH, Sdepanian VL, Szejnfeld VL, de Morais MB, Fagundes-Neto U.
    Dig Dis Sci; 2008 Oct; 53(10):2746-53. PubMed ID: 18351466
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ, van der Kaay DC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V, Briot K, Roux C, Roy C, Seksik P, Charachon A, Bouhnik Y, Coffin B, Allez M, Lamarque D, Chaussade S.
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
    Nobile S, Grand RJ, Pappa HM.
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):471-476. PubMed ID: 29438136
    [Abstract] [Full Text] [Related]

  • 20. Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients?
    Walldorf J, Krummenerl A, Engler K, Busch J, Dollinger MM, Seufferlein T, Albert JG.
    J Crohns Colitis; 2013 Dec; 7(11):901-7. PubMed ID: 23333038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.